480-907-7690 info@qfrsolutions.com
Jazz Pharma to buy Celator in $1.5 billion deal

Jazz Pharma to buy Celator in $1.5 billion deal

Source: Reuters Ireland-based Jazz Pharmaceuticals Plc will buy U.S.-based Celator Pharmaceuticals Inc in a cash deal valued at about $1.5 billion, to gain access to an investigational product in development for treating acute myeloid leukemia. Jazz Pharmaceuticals...